Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuogui Jiangtang Shuluo Formula for Diabetic Peripheral Neuropathy
NCT07771894Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of Zuogui Jiangtang Shuluo Formula in diabetic peripheral neuropathy (DPN) (3 arms). Primary endpoints: Nerve Conduction Velocity at 4 weeks, Toronto Clinical Scoring System at 4 weeks and 1 more. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
Zuogui Jiangtang Shuluo Formula
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07771894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07771894.